ClinicalTrials.gg
CompletedNCT07053683Updated Aug 22, 2025

Efficacy of RME and Facemask Therapy for Class III Malocclusion

An interventional study of Combined RME and Facemask Therapy and Facemask Therapy Alone in Skeletal Class III Malocclusion, sponsored by Wuhan Integrated Traditional Chinese and Western Medicine Hospital. Completed at 1 site in China. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Wuhan Integrated Traditional Chinese and Western Medicine Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 years 5 months after the study started (first participant enrolled Jan 2019, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
358
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

This multicenter randomized controlled trial compares the efficacy of Rapid Maxillary Expansion (RME) combined with facemask (FM) protraction versus FM protraction alone in treating growing children with skeletal Class III malocclusion. The study aims to evaluate the differences in vertical skeletal changes and Oral Health-Related Quality of Life (OHRQoL) between the two treatments.

Read the detailed description

Skeletal Class III malocclusion is a challenging craniofacial anomaly, particularly prevalent in Asian populations. Early orthopedic intervention aims to correct the discrepancy and guide favorable growth. While facemask (FM) protraction is a standard treatment, its efficacy can be enhanced by Rapid Maxillary Expansion (RME), which is thought to disarticulate the circummaxillary sutures and facilitate a better orthopedic response. This prospective, multicenter, randomized controlled trial was designed to rigorously compare the combined RME+FM therapy against FM therapy alone. The study's primary objective was to assess the impact of these interventions on vertical skeletal dimensions, a key concern in Class III treatment. The secondary objective was to evaluate the patient-centered outcome of Oral Health-Related Quality of Life (OHRQoL). Eligible patients aged 7-12 were randomly assigned to one of two treatment groups. Cephalometric and OHRQoL data were collected at baseline and after 12 months of active treatment to determine if the combined approach offers superior clinical outcomes.

02

Conditions studied

  • Skeletal Class III Malocclusion

Keywords

  • Palatal Expansion Technique
  • Extraoral Traction Appliances
  • Malocclusion
  • Angle Class III
  • Cephalometry
  • Rapid Maxillary Expansion
  • Oral Health-Related Quality of Life
03

In context

Malocclusion

323 studies on the registry are indexed under Malocclusion; 85 are open to participants now.

This study's enrollment of 358 is above the median of 37 across 242 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

Wuhan Integrated Traditional Chinese and Western Medicine Hospital is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Skeletal Class III malocclusion (ANB angle ≤ 0°) with a Wits appraisal ≤ -2 mm.
  • Maxillary deficiency (SNA angle ≤ 80°).
  • Prepubertal stage of skeletal development (Cervical Vertebral Maturation Stage CS1-CS3).
  • Age between 7 and 12 years.
  • Anterior crossbite or edge-to-edge incisor relationship.
  • Angle Class III or end-on molar relationship.
  • No previous orthodontic treatment.

Exclusion criteria

Exclusion Criteria:

  • Functional Class III malocclusion with no centric relation-centric occlusion discrepancy.
  • Congenital craniofacial anomalies (e.g., cleft lip/palate).
  • Severe systemic diseases.
  • History of maxillofacial trauma.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
358 participants (actual)

Study arms

  • Experimental
    Experimental: RME+FM Group

    Patients received a tooth-borne Hyrax-type rapid maxillary expander. After the active expansion phase, a Petit-type facemask was delivered, applying a forward and downward protraction force of 400-500g per side for 12-14 hours per day.

    Device: Combined RME and Facemask Therapy

  • Active comparator
    Control: Facemask (FM) Alone Group

    Patients received the same facemask protraction therapy as the experimental group (same force, direction, and duration) but without undergoing RME. A removable mandibular occlusal splint was provided to disarticulate the occlusion.

    Device: Facemask Therapy Alone

Interventions

  • DeviceCombined RME and Facemask Therapy

    This intervention involves two components. First, a tooth-borne Hyrax-type rapid maxillary expander is banded to the maxillary first permanent and deciduous molars. The screw is activated twice daily until posterior crossbite is overcorrected. Second, immediately following expansion, a Petit-type facemask is used to apply orthopedic protraction forces to the maxilla.

  • DeviceFacemask Therapy Alone

    This intervention involves the use of a Petit-type facemask to apply orthopedic protraction forces (400-500g per side, 12-14 hours/day) to the maxilla. A removable mandibular occlusal splint (flat bite plane) is used concurrently to facilitate anterior crossbite correction.

06

What researchers measure

Primary outcomes

  1. Change in Vertical Linear Cephalometric Measurements

    Measured from standardized lateral cephalograms and Cone-Beam Computed Tomography (CBCT) scans. Key measurements include overbite (mm), maxillary molar vertical position (PP-Ms distance, mm), and maxillary anterior position (X-A distance, mm).

    Time frame: Baseline, 12 Months

  2. Change in Angular Cephalometric Measurements

    Measured from standardized lateral cephalograms and CBCT scans. Key measurements include sagittal jaw relationship (ANB angle, degrees), mandibular plane angle (SN-MP, degrees), and palatal plane angle (SN-PP, degrees).

    Time frame: Baseline, 12 Months

Secondary outcomes

  1. Change in Dental Positional Measurements

    Change in cephalometric measurements assessing the position and inclination of the incisors, including the UI-NA angle, UI-LI angle (upper to lower incisor angle), UI-NA distance (upper incisor protrusion), and LI-NB distance (lower incisor position). These are measured in degrees or millimeters as appropriate.

    Time frame: Baseline (T0) and 6-month follow-up (T1).

  2. Change in Dental Cephalometric Measurements

    Measured from lateral cephalograms to assess changes in the inclination of the maxillary and mandibular incisors.

    Time frame: Baseline, 12 Months

07

Study locations

1 site
  • Wuhan No.1 Hospital
    Wuhan, Hubei 430000, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2019 to primary completion in Dec 2023, 59 months.

Of 153 non-industry interventional studies with no phase under Malocclusion, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 30. This study's 59 months is above that.

Counting every sponsor, half of 163 studies reached it within 19 months; a quarter within 10 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2025
First posted
Jul 8, 2025
StartActual
Jan 1, 2019
Primary completionActual
Dec 31, 2023
CompletionActual
Dec 31, 2023
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07053683
Lead sponsor
Wuhan Integrated Traditional Chinese and Western Medicine Hospital
Responsible party
Lulu Wang (Principal investigator, Wuhan Integrated Traditional Chinese and Western Medicine Hospital) — Principal investigator
First posted
Jul 8, 2025
Start date
Jan 1, 2019
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Aug 22, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion